Physician profile

Daniel A Feldman

Interventional Cardiology · Portland, OR

NPI 1033351093

$36,197.32

in general payments reported to CMS, 2019-2025

14 companies · $33K in 2025

The $33K reported for 2025 was more than what 95% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Consulting Fee$32,475.00
Food and Beverage$1,662.70
Travel and Lodging$1,246.86

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Abiomed $32,681.70 2022-2025 Impella
Abbott Laboratories $1,606.23 2021-2024 Mitraclip, Supera, Omnilink Elite
Medtronic, INC. $618.20 2022-2025 Corevalve Evolut R, Plasmablade(Tm)
Edwards Lifesciences Corporation $520.22 2021-2025 Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv)
Boston Scientific Corporation $285.09 2019-2025 Watchman Access System
Biosense Webster, INC. $144.12 2024-2025 Nuvision Ice Catheter, Carto 3
Pfizer INC. $118.57 2024-2025
Shockwave Medical, INC $46.62 2022-2024 Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave C2+ Coronary
Cordis US Corp. $40.25 2025 Mynx Control Venous
Cardiovascular Systems INC. $38.51 2019-2021
Stryker Corporation $30.97 2025 Ct Thrombectomy System Kit, Flowtriever Catheter, S
Inari Medical, INC. $24.33 2025 Ct Thrombectomy System Kit, Flowtriever Catheter, S
Penumbra, INC. $22.70 2022
Cardiva Medical, INC. $19.81 2023 Cardiva Vascade 6/7f Vcs

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Daniel A Feldman

$36,197.32

in general payments reported 2019-2025

Years
2019-2025
Top company
Abiomed
Context
The $33K reported for 2025 was more than what 95% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).

https://glasscript.com/doctor/1305492/daniel-a-feldman

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.